Jul 042010
 

New anti-radiation drug

Radiation is a frontline treatment for many cancers.

However, its therapeutic value can come at the cost of damage to the bone marrow which produces all of the body’s red and white blood cells and platelets, so finding ways to protect bone marrow is a research priority. A study by the UNC Lineberger Comprehensive Cancer Center has shown that the drug PQ can successfully protect mice from lethal doses of radiation.

Researchers hope PQ will be able to protect humans who are exposed to high doses of radiation, either intentional, such as cancer patients, or accidental – for example, disaster victims.

PQ (pharmacological quiescence) inhibits enzymes involved in cell division and temporarily prevents some types of bone marrow cells from dividing. it has been known for several decades that cells which don’t divide are resistant to agents such as radiation that damage DNA, but this is the first successful example of radiomitigation in mammals.

Mice that were given PQ orally immediately before or up to 20 hours after exposure to radiation showed normal counts of red and white blood cells and platelets.

“We have identified a simple, non-toxic pill that decreases radiation toxicity even when given after radiation exposure,” said Norman Sharpless, UNC Lineberger Associate Director for Translational Research and an associate professor of medicine and genetics at UNC’s School of Medicine.

Read more . . .

Other Interesting Posts

Leave a Reply

%d bloggers like this: